Lisata Therapeutics
LSTA
50 hedge funds and large institutions have $17.9M invested in Lisata Therapeutics in 2014 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 13 closing their positions.
14% less funds holding
Funds holding: 58 → 50 (-8)
15% less capital invested
Capital invested by funds: $21M → $17.9M (-$3.13M)
19% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 16
47% less call options, than puts
Call options by funds: $432K | Put options by funds: $819K
62% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
+$1.07M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$594K |
| 3 |
TFO
Tarbox Family Office
Newport Beach,
California
|
+$564K |
| 4 |
State Street
Boston,
Massachusetts
|
+$149K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$122K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$560K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$418K |
| 3 |
SG Americas Securities
New York
|
-$254K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$162K |
| 5 |
HCM
Highbridge Capital Management
New York
|
-$146K |
LSTA Hedge Fund Activity: Q3 2014 in Review
50 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Lisata Therapeutics (LSTA) for Q3 2014, worth a combined $17.9M — down 15% from $21M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of LSTA and 5 opened new positions — a net loss of 8 holders — while 16 trimmed existing stakes and 13 added.
The largest buyer was Northern Trust, adding an estimated $1.07M. The largest seller was Jane Street, exiting entirely with an estimated $560K sold.
- 50 institutional investors held Lisata Therapeutics (LSTA) as of Q3 2014, down from 58 in Q2 2014.
- Funds reported $17.9M of Lisata Therapeutics stock for Q3 2014, down 15% quarter-over-quarter.
- 5 funds opened new Lisata Therapeutics positions in Q3 2014 and 13 closed out, a net change of -8 holders.
- The largest Lisata Therapeutics buyer in Q3 2014 was Northern Trust, an estimated $1.07M added.
- The largest Lisata Therapeutics seller in Q3 2014 was Jane Street, an estimated $560K sold.
Based on aggregated 13F filings for Q3 2014.